PTGER3 and type 2 diabetes mellitus: Because the EP3 and EP4 receptors have been shown to have effects on β‐cell proliferation, survival, and function as well as cardiac function, we propose that modulating these receptors would have positive effects on both CVD and T2D, and thereby potentially treat both diseases simultaneously.